b60c93254b06321f…

{
  "id": "NCT00024531",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease.",
    "completionDate": "2004-08",
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": 98,
    "enrollmentType": null,
    "nctId": "NCT00024531",
    "phase": "PHASE2",
    "sponsorId": "institute-for-the-study-of-aging-isoa",
    "startDate": "2000-10",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00024531"
  }
}